Indian Journal of Nephrology Home 

ORIGINAL ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2018  |  Volume : 28  |  Issue : 3  |  Page : 203--208

Adrenocortical suppression in children with nephrotic syndrome treated with low-dose alternate day corticosteroids

M Mantan1, R Grover1, S Kaushik2, S Yadav1 
1 Department of Pediatrics, Maulana Azad Medical College and Associated Lok Nayak Hospital, University of Delhi, New Delhi, India
2 Department of Biochemistry, Maulana Azad Medical College and Associated Lok Nayak Hospital, University of Delhi, New Delhi, India

Correspondence Address:
M Mantan
Department of Pediatrics, Maulana Azad Medical College, New Delhi - 110 002
India

Corticosteroids form the mainstay of therapy for all forms of nephrotic syndrome. The long-term use of this medication is associated with serious side effects including adrenocortical suppression. The primary objective of this study was to identify adrenocortical suppression (assessed by single morning serum cortisol levels) in children with nephrotic syndrome on treatment with low-dose alternate day steroids. This cross-sectional study was conducted in the Department of Pediatrics in a tertiary care hospital from January 2014 to January 2015. Seventy children (1–18 years) with nephrotic syndrome (steroid sensitive and resistant) who were in remission and on low-dose alternate day steroids for at least 8 weeks or had received steroids of 2 mg/kg/d for at least 2 weeks in the last 1 year (infrequent relapsers) were enrolled. Relevant history was taken, clinical examination was done and blood samples were drawn for serum cortisol, lipid profile, kidney function tests, fasting blood sugar, glycated hemoglobin (HbA1c), and serum albumin. Forty percent (28/70) children had adrenocortical suppression as assessed by low morning serum cortisol levels. The mean serum cortisol levels were 188 nmol/L and were significantly lower in frequently relapsing individuals (85.9 nmol/L) as compared to other types of nephrotic syndrome (P = 0.05). The prevalence of adrenocortical suppression was higher in steroid-resistant patients (57%) as compared to 28% in frequently relapsing and 11% in steroid-dependent patients. Fifty-seven percent of patients with adrenocortical suppression had short stature while 50% had obesity. All individuals had normal serum HbA1clevels. The cumulative steroid doses and total duration of corticosteroid therapy were significantly higher in patients with adrenocortical suppression. Children with nephrotic syndrome treated with low-dose alternate day steroids have a high prevalence of adrenocortical suppression on screening with single morning cortisol sample. Those with frequently relapsing or steroid-resistant diseases are at a higher risk of suppression.

How to cite this article:
Mantan M, Grover R, Kaushik S, Yadav S. Adrenocortical suppression in children with nephrotic syndrome treated with low-dose alternate day corticosteroids.Indian J Nephrol 2018;28:203-208

How to cite this URL:
Mantan M, Grover R, Kaushik S, Yadav S. Adrenocortical suppression in children with nephrotic syndrome treated with low-dose alternate day corticosteroids. Indian J Nephrol [serial online] 2018 [cited 2019 Dec 6 ];28:203-208
Available from: http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2018;volume=28;issue=3;spage=203;epage=208;aulast=Mantan;type=0